PhRMA

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf trade association
gptkbp:addresses drug pricing issues
gptkbp:advocatesFor patient rights
research funding
intellectual property protections
fair regulatory processes
gptkbp:aimsTo improve patient access to medicines
gptkbp:collaboratesWith healthcare_stakeholders
gptkbp:conducts educational initiatives
surveys on public opinion
gptkbp:engagesIn community outreach
public policy discussions
gptkbp:focusesOn advocacy for pharmaceutical research
gptkbp:founded 1958
gptkbp:hasArea code of ethics
gptkbp:hasCollaborationsWith non-profit organizations
gptkbp:hasDescription diversity in clinical trials
gptkbp:hasEstablished partnerships with universities
gptkbp:hasInfluenceOn healthcare_policy
gptkbp:hasPrograms patient assistance
healthcare_access
gptkbp:headquarters gptkb:Washington,_D.C.
https://www.w3.org/2000/01/rdf-schema#label PhRMA
gptkbp:isA gptkb:non-profit_organization
lobbying organization
key player in the pharmaceutical industry
leading voice in biopharmaceutical policy
member_of_the_U.S._Chamber_of_Commerce
gptkbp:isActiveIn legislative advocacy
gptkbp:isDedicatedTo advancing medical research
gptkbp:isEngagedIn international collaborations
gptkbp:isFocusedOn sustainable healthcare solutions
healthcare_innovation
gptkbp:isInvolvedIn patient education
global health initiatives
policy research
healthcare_reform_discussions
gptkbp:members more than 30 leading biopharmaceutical companies
gptkbp:participatesIn conferences and events
gptkbp:promotes patient-centered care
innovation in drug development
gptkbp:provides information on drug safety
resources for healthcare professionals
guidance on drug development
research and data on drug development
gptkbp:publishes annual reports
gptkbp:represents biopharmaceutical companies
gptkbp:supports clinical trials
clinical research
biomedical research
innovation in healthcare delivery
gptkbp:worksWith government agencies